Annual FCF
-$335.52 M
-$41.05 M-13.94%
31 December 2023
Summary:
Ionis Pharmaceuticals annual free cash flow is currently -$335.52 million, with the most recent change of -$41.05 million (-13.94%) on 31 December 2023. During the last 3 years, it has fallen by -$330.37 million (-6407.45%). IONS annual FCF is now -157.33% below its all-time high of $585.25 million, reached on 31 December 2018.IONS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$111.30 M
+$28.84 M+20.58%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly free cash flow is currently -$111.30 million, with the most recent change of +$28.84 million (+20.58%) on 30 September 2024. Over the past year, it has increased by +$967.00 thousand (+0.86%). IONS quarterly FCF is now -122.60% below its all-time high of $492.49 million, reached on 30 June 2018.IONS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$374.21 M
+$967.00 K+0.26%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM free cash flow is currently -$374.21 million, with the most recent change of +$967.00 thousand (+0.26%) on 30 September 2024. Over the past year, it has increased by +$199.40 million (+34.76%). IONS TTM FCF is now -155.14% below its all-time high of $678.61 million, reached on 31 March 2019.IONS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.9% | +0.9% | +34.8% |
| 3 y3 years | -6407.4% | -85.0% | -291.0% |
| 5 y5 years | -157.3% | -263.8% | -343.2% |
IONS Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2701.4% | at low | -155.7% | +45.8% | -438.9% | +34.8% |
| 5 y | 5 years | -157.3% | at low | -141.4% | +45.8% | -221.0% | +34.8% |
| alltime | all time | -157.3% | at low | -122.6% | +45.8% | -155.1% | +34.8% |
Ionis Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$111.30 M(-20.6%) | -$374.21 M(-0.3%) |
| June 2024 | - | -$140.14 M(-10.0%) | -$375.18 M(+8.6%) |
| Mar 2024 | - | -$155.67 M(-573.3%) | -$345.48 M(+3.0%) |
| Dec 2023 | -$335.52 M(+13.9%) | $32.89 M(-129.3%) | -$335.52 M(-41.5%) |
| Sept 2023 | - | -$112.26 M(+1.7%) | -$573.62 M(+16.4%) |
| June 2023 | - | -$110.44 M(-24.2%) | -$492.84 M(+21.7%) |
| Mar 2023 | - | -$145.72 M(-29.0%) | -$405.00 M(+37.5%) |
| Dec 2022 | -$294.47 M(-2383.1%) | -$205.20 M(+551.7%) | -$294.47 M(-366.7%) |
| Sept 2022 | - | -$31.49 M(+39.3%) | $110.43 M(+35.1%) |
| June 2022 | - | -$22.60 M(-35.8%) | $81.75 M(+131.1%) |
| Mar 2022 | - | -$35.18 M(-117.6%) | $35.38 M(+174.3%) |
| Dec 2021 | $12.90 M(-350.2%) | $199.70 M(-431.9%) | $12.90 M(-113.5%) |
| Sept 2021 | - | -$60.17 M(-12.7%) | -$95.70 M(+62.8%) |
| June 2021 | - | -$68.96 M(+19.6%) | -$58.77 M(+29.9%) |
| Mar 2021 | - | -$57.66 M(-163.3%) | -$45.24 M(+777.5%) |
| Dec 2020 | -$5.16 M(-101.7%) | $91.10 M(-491.9%) | -$5.16 M(-103.0%) |
| Sept 2020 | - | -$23.25 M(-58.1%) | $172.64 M(+4.4%) |
| June 2020 | - | -$55.44 M(+215.4%) | $165.29 M(-12.2%) |
| Mar 2020 | - | -$17.58 M(-106.5%) | $188.32 M(-39.1%) |
| Dec 2019 | $309.35 M(-47.1%) | $268.90 M(-979.0%) | $309.35 M(+101.1%) |
| Sept 2019 | - | -$30.59 M(-5.6%) | $153.84 M(+0.1%) |
| June 2019 | - | -$32.40 M(-131.3%) | $153.72 M(-77.3%) |
| Mar 2019 | - | $103.44 M(-8.8%) | $678.61 M(+16.0%) |
| Dec 2018 | $585.25 M(+329.4%) | $113.39 M(-469.2%) | $585.25 M(+20.6%) |
| Sept 2018 | - | -$30.71 M(-106.2%) | $485.19 M(-7.6%) |
| June 2018 | - | $492.49 M(+4783.8%) | $524.88 M(+1779.2%) |
| Mar 2018 | - | $10.08 M(-24.4%) | $27.93 M(-79.5%) |
| Dec 2017 | $136.29 M(-210.2%) | $13.34 M(+48.6%) | $136.29 M(+47.7%) |
| Sept 2017 | - | $8.97 M(-301.1%) | $92.28 M(-12.4%) |
| June 2017 | - | -$4.46 M(-103.8%) | $105.36 M(+47.2%) |
| Mar 2017 | - | $118.44 M(-486.1%) | $71.59 M(-157.9%) |
| Dec 2016 | -$123.63 M(-1418.5%) | -$30.68 M(-239.1%) | -$123.63 M(-7.4%) |
| Sept 2016 | - | $22.06 M(-157.7%) | -$133.56 M(+9.2%) |
| June 2016 | - | -$38.23 M(-50.2%) | -$122.33 M(+432.4%) |
| Mar 2016 | - | -$76.78 M(+89.1%) | -$22.98 M(-345.0%) |
| Dec 2015 | $9.38 M(-294.6%) | -$40.61 M(-222.0%) | $9.38 M(-91.9%) |
| Sept 2015 | - | $33.29 M(-45.5%) | $115.98 M(+39.6%) |
| June 2015 | - | $61.12 M(-237.6%) | $83.11 M(-647.5%) |
| Mar 2015 | - | -$44.42 M(-167.3%) | -$15.18 M(+215.0%) |
| Dec 2014 | -$4.82 M(-108.3%) | $65.99 M(>+9900.0%) | -$4.82 M(-94.5%) |
| Sept 2014 | - | $423.00 K(-101.1%) | -$86.83 M(+269.4%) |
| June 2014 | - | -$37.17 M(+9.1%) | -$23.50 M(-166.1%) |
| Mar 2014 | - | -$34.06 M(+112.6%) | $35.57 M(-38.8%) |
| Dec 2013 | $58.13 M(-1864.8%) | -$16.02 M(-125.1%) | $58.13 M(-46.6%) |
| Sept 2013 | - | $63.75 M(+191.1%) | $108.83 M(+477.3%) |
| June 2013 | - | $21.90 M(-290.5%) | $18.85 M(-347.4%) |
| Mar 2013 | - | -$11.50 M(-133.2%) | -$7.62 M(+131.4%) |
| Dec 2012 | -$3.29 M(-97.4%) | $34.68 M(-232.2%) | -$3.29 M(-94.8%) |
| Sept 2012 | - | -$26.23 M(+473.8%) | -$63.10 M(-1.1%) |
| June 2012 | - | -$4.57 M(-36.3%) | -$63.79 M(-29.2%) |
| Mar 2012 | - | -$7.17 M(-71.5%) | -$90.04 M(-28.4%) |
| Dec 2011 | -$125.80 M(+55.0%) | -$25.13 M(-6.6%) | -$125.80 M(-1.4%) |
| Sept 2011 | - | -$26.91 M(-12.7%) | -$127.56 M(+3.0%) |
| June 2011 | - | -$30.83 M(-28.2%) | -$123.89 M(+36.4%) |
| Mar 2011 | - | -$42.93 M(+59.7%) | -$90.86 M(+12.0%) |
| Dec 2010 | -$81.15 M(-34.9%) | -$26.89 M(+15.7%) | -$81.15 M(-8.1%) |
| Sept 2010 | - | -$23.25 M(-1153.9%) | -$88.34 M(-11.0%) |
| June 2010 | - | $2.21 M(-106.6%) | -$99.22 M(-17.5%) |
| Mar 2010 | - | -$33.22 M(-2.5%) | -$120.20 M(-3.6%) |
| Dec 2009 | -$124.73 M(-164.0%) | -$34.08 M(-0.2%) | -$124.73 M(+6.4%) |
| Sept 2009 | - | -$34.14 M(+81.9%) | -$117.26 M(+7.7%) |
| June 2009 | - | -$18.77 M(-50.3%) | -$108.85 M(-230.3%) |
| Mar 2009 | - | -$37.75 M(+41.9%) | $83.56 M(-57.1%) |
| Dec 2008 | $194.96 M(+527.2%) | -$26.61 M(+3.4%) | $194.96 M(-26.8%) |
| Sept 2008 | - | -$25.72 M(-114.8%) | $266.28 M(-12.0%) |
| June 2008 | - | $173.64 M(+135.7%) | $302.73 M(+139.4%) |
| Mar 2008 | - | $73.66 M(+64.8%) | $126.43 M(+306.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $31.08 M(-155.7%) | $44.70 M(+316.7%) | $31.08 M(-229.8%) |
| Sept 2007 | - | $10.73 M(-503.2%) | -$23.95 M(-51.4%) |
| June 2007 | - | -$2.66 M(-87.7%) | -$49.30 M(-18.9%) |
| Mar 2007 | - | -$21.69 M(+110.1%) | -$60.77 M(+9.0%) |
| Dec 2006 | -$55.78 M(-12.7%) | -$10.32 M(-29.4%) | -$55.78 M(-9.5%) |
| Sept 2006 | - | -$14.62 M(+3.4%) | -$61.60 M(+16.5%) |
| June 2006 | - | -$14.14 M(-15.3%) | -$52.86 M(-9.3%) |
| Mar 2006 | - | -$16.69 M(+3.4%) | -$58.30 M(-8.8%) |
| Dec 2005 | -$63.92 M(-39.3%) | -$16.15 M(+174.6%) | -$63.92 M(-13.2%) |
| Sept 2005 | - | -$5.88 M(-70.0%) | -$73.66 M(-18.7%) |
| June 2005 | - | -$19.58 M(-12.2%) | -$90.64 M(-12.9%) |
| Mar 2005 | - | -$22.31 M(-13.8%) | -$104.02 M(-1.2%) |
| Dec 2004 | -$105.28 M(+2.2%) | -$25.89 M(+13.2%) | -$105.28 M(-7.0%) |
| Sept 2004 | - | -$22.86 M(-30.6%) | -$113.21 M(-0.6%) |
| June 2004 | - | -$32.95 M(+39.8%) | -$113.90 M(+8.4%) |
| Mar 2004 | - | -$23.57 M(-30.3%) | -$105.04 M(+2.0%) |
| Dec 2003 | -$103.03 M(-21.5%) | -$33.83 M(+43.6%) | -$103.03 M(+10.7%) |
| Sept 2003 | - | -$23.55 M(-2.2%) | -$93.08 M(-0.6%) |
| June 2003 | - | -$24.09 M(+11.7%) | -$93.64 M(-28.4%) |
| Mar 2003 | - | -$21.56 M(-9.7%) | -$130.81 M(-0.3%) |
| Dec 2002 | -$131.22 M(+749.6%) | -$23.87 M(-1.0%) | -$131.22 M(+7.2%) |
| Sept 2002 | - | -$24.11 M(-60.6%) | -$122.41 M(+71.3%) |
| June 2002 | - | -$61.27 M(+179.0%) | -$71.44 M(+271.2%) |
| Mar 2002 | - | -$21.96 M(+45.7%) | -$19.25 M(+24.6%) |
| Dec 2001 | -$15.45 M(-37.8%) | -$15.07 M(-156.1%) | -$15.45 M(+198.8%) |
| Sept 2001 | - | $26.85 M(-396.0%) | -$5.17 M(-83.7%) |
| June 2001 | - | -$9.07 M(-50.0%) | -$31.75 M(+1.3%) |
| Mar 2001 | - | -$18.16 M(+278.9%) | -$31.34 M(+26.2%) |
| Dec 2000 | -$24.84 M(-53.3%) | -$4.79 M(-1901.5%) | -$24.84 M(-23.5%) |
| Sept 2000 | - | $266.00 K(-103.1%) | -$32.44 M(-26.6%) |
| June 2000 | - | -$8.65 M(-25.7%) | -$44.21 M(-9.9%) |
| Mar 2000 | - | -$11.65 M(-6.0%) | -$49.05 M(-7.8%) |
| Dec 1999 | -$53.20 M(+36.1%) | -$12.40 M(+7.8%) | -$53.20 M(+1.3%) |
| Sept 1999 | - | -$11.50 M(-14.8%) | -$52.50 M(+2.1%) |
| June 1999 | - | -$13.50 M(-14.6%) | -$51.40 M(+40.4%) |
| Mar 1999 | - | -$15.80 M(+35.0%) | -$36.60 M(-6.4%) |
| Dec 1998 | -$39.10 M(+62.2%) | -$11.70 M(+12.5%) | -$39.10 M(+17.1%) |
| Sept 1998 | - | -$10.40 M(-900.0%) | -$33.40 M(+31.0%) |
| June 1998 | - | $1.30 M(-107.1%) | -$25.50 M(-29.2%) |
| Mar 1998 | - | -$18.30 M(+205.0%) | -$36.00 M(+49.4%) |
| Dec 1997 | -$24.10 M(+9.0%) | -$6.00 M(+140.0%) | -$24.10 M(-0.4%) |
| Sept 1997 | - | -$2.50 M(-72.8%) | -$24.20 M(-12.6%) |
| June 1997 | - | -$9.20 M(+43.8%) | -$27.70 M(+3.7%) |
| Mar 1997 | - | -$6.40 M(+4.9%) | -$26.70 M(+20.8%) |
| Dec 1996 | -$22.10 M(+36.4%) | -$6.10 M(+1.7%) | -$22.10 M(-6.4%) |
| Sept 1996 | - | -$6.00 M(-26.8%) | -$23.60 M(+38.0%) |
| June 1996 | - | -$8.20 M(+355.6%) | -$17.10 M(+37.9%) |
| Mar 1996 | - | -$1.80 M(-76.3%) | -$12.40 M(-23.5%) |
| Dec 1995 | -$16.20 M(+0.6%) | -$7.60 M(-1620.0%) | -$16.20 M(+33.9%) |
| Sept 1995 | - | $500.00 K(-114.3%) | -$12.10 M(-16.0%) |
| June 1995 | - | -$3.50 M(-37.5%) | -$14.40 M(0.0%) |
| Mar 1995 | - | -$5.60 M(+60.0%) | -$14.40 M(-10.6%) |
| Dec 1994 | -$16.10 M(-21.5%) | -$3.50 M(+94.4%) | -$16.10 M(-7.5%) |
| Sept 1994 | - | -$1.80 M(-48.6%) | -$17.40 M(-8.4%) |
| June 1994 | - | -$3.50 M(-52.1%) | -$19.00 M(-14.8%) |
| Mar 1994 | - | -$7.30 M(+52.1%) | -$22.30 M(+8.8%) |
| Dec 1993 | -$20.50 M(-4.7%) | -$4.80 M(+41.2%) | -$20.50 M(+5.7%) |
| Sept 1993 | - | -$3.40 M(-50.0%) | -$19.40 M(-10.2%) |
| June 1993 | - | -$6.80 M(+23.6%) | -$21.60 M(+9.1%) |
| Mar 1993 | - | -$5.50 M(+48.6%) | -$19.80 M(-7.9%) |
| Dec 1992 | -$21.50 M(+388.6%) | -$3.70 M(-33.9%) | -$21.50 M(+11.4%) |
| Sept 1992 | - | -$5.60 M(+12.0%) | -$19.30 M(+14.9%) |
| June 1992 | - | -$5.00 M(-30.6%) | -$16.80 M(+21.7%) |
| Mar 1992 | - | -$7.20 M(+380.0%) | -$13.80 M(+213.6%) |
| Dec 1991 | -$4.40 M | -$1.50 M(-51.6%) | -$4.40 M(+51.7%) |
| Sept 1991 | - | -$3.10 M(+55.0%) | -$2.90 M(-1550.0%) |
| June 1991 | - | -$2.00 M(-190.9%) | $200.00 K(-90.9%) |
| Mar 1991 | - | $2.20 M | $2.20 M |
FAQ
- What is Ionis Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual FCF year-on-year change?
- What is Ionis Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly FCF year-on-year change?
- What is Ionis Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM FCF year-on-year change?
What is Ionis Pharmaceuticals annual free cash flow?
The current annual FCF of IONS is -$335.52 M
What is the all time high annual FCF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual free cash flow is $585.25 M
What is Ionis Pharmaceuticals annual FCF year-on-year change?
Over the past year, IONS annual free cash flow has changed by -$41.05 M (-13.94%)
What is Ionis Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of IONS is -$111.30 M
What is the all time high quarterly FCF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly free cash flow is $492.49 M
What is Ionis Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, IONS quarterly free cash flow has changed by +$967.00 K (+0.86%)
What is Ionis Pharmaceuticals TTM free cash flow?
The current TTM FCF of IONS is -$374.21 M
What is the all time high TTM FCF for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM free cash flow is $678.61 M
What is Ionis Pharmaceuticals TTM FCF year-on-year change?
Over the past year, IONS TTM free cash flow has changed by +$199.40 M (+34.76%)